Variables |
Frequency |
Percent |
Gender |
|
|
Male |
20 |
66.7 |
Female |
10 |
33.3 |
Type of tumor |
|
|
AML |
4 |
13.3 |
ALL |
9 |
30.0 |
Ca.breast |
2 |
6.7 |
Burkitt's lymphoma |
2 |
6.7 |
Colorectal carcinoma |
1 |
3.3 |
HL |
3 |
10.0 |
NHL |
4 |
13.3 |
Wilm's tumor |
1 |
3.3 |
Neuroblastoma |
1 |
3.3 |
PNET |
2 |
6.7 |
Osteosarcoma |
1 |
3.3 |
Drug groups |
|
|
Adriamycine ,Bleomycin, Decarbazine, Vinblastin |
1 |
3.3 |
Etoposide, Ifosfamide, Mesna |
4 |
13.3 |
Daunorubicin, Cytosar |
4 |
13.3 |
Methotrexate, Vincristion, Adriamycine |
1 |
3.3 |
Daunorubicin, Methotrexate, Cychlophosphamide, Cytosar |
2 |
6.7 |
Methotrexate, Cytosar, L-asparginase |
1 |
3.3 |
Etoposide, Ifosfamide, Decarbazine, Doxorubicine |
1 |
3.3 |
Daunorubicin, Cytosar, Vincristin, L-asparginase |
4 |
13.3 |
Bleomycin, Decarbazine, Vinblastin |
1 |
3.3 |
Vincristin ,Cychlophosphamide, Doxorubicine |
2 |
6.7 |
Adriamycine ,Bleomycin, Decarbazine, Vincristin |
1 |
3.3 |
Daunorubicin, Vincristin, L-asparginase, Pridinisolone |
2 |
6.7 |
Methotrexate ,Cychlophosphamide, 5-fluruouracil |
2 |
6.7 |
5-fluruouracil, Oxaloplatin, Avastin |
1 |
3.3 |
Methotrexate, Vincristin, Cychlophosphamide, Adriamycine |
1 |
3.3 |
Cytosar, Vincristin, L-asparginase, Cychlophosphamide |
1 |
3.3 |
Vincristin, L-asparginase, Cychlophosphamide, Predinisolone |
1 |
3.3 |
Total |
30 |
100 |
|
